Investigates glutathione levels in primary mitochondrial disease, suggesting metabolic differences from healthy controls.
Novel evaluation of brain glutathione (GSH) levels in Primary Mitochondrial Disease (PMD) patients by edited Magnetic Resonance Spectroscopy (MRS) compared to healthy controls.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: